Sam Chang, MD, MBA, who has served as chair of the American Urological Association (AUA) guidelines panel for non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC), provides an overview of updated non-metastatic MIBC treatment guidelines, including a comprehensive treatment algorithm. He also discusses directions of future research for the disease.
Read More
Sam Chang, MD, MBA, delineates the benefits and shortcomings of both robotic and open cystectomy, specifically in terms of morbidity, compilation, and recurrence rates for patients, and the learning curve associated with each method for clinicians. He also discusses how the financial cost of robotic surgery factors into this comparison.
Read More
Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer...
Read More
Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and...
Read More
Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer ...
Read More